Newbury Pharma is a rapidly growing hybrid pharmaceutical company focused on specialty prescription drugs, innovation, and branded products. The company aims to impact society positively by bringing products and technology that contribute to healthcare systems and patient wellbeing. Newbury Pharmaceuticals is developing a pipeline of proprietary and licensed products with a focus on oncology, rare diseases, and neurology.

Newbury Pharma

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.

NEWB

COM:NEWBURYPHARMA

Newbury Pharma

Last Close

3.32

25/11 08:40

Market Cap

91.21M

Beta: -

Volume Today

4.70K

Avg: -

Filings Not Available